drugset / Trial / NCT04669197
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the normalization rate of CA 19-9 of individuals with non-metastatic pancreas cancer following up to 6 months of neoadjuvant chemotherapy.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2024-02-21
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Hydroxychloroquine | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |